SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization

Molecular Cell

Volumn 10, Issue 4, 2002, Pages 831-842

  Ross, Sarah ^a   Best, Jennifer L ^a   Zon, Leonard I ^a   Gill, Grace ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUMO 1 PROTEIN; TRANSCRIPTION FACTOR SP3;

ARTICLE; GENE FUSION; GENE MUTATION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

EID: 0036809115     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00682-2     Document Type: Article

References (60)

1. Apt D., Watts R.M., Suske G., Bernard H.U. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology. 224:1996;281-291.
2. Best J.L., Ganiatsas S., Agarwal S., Changou A., Salomoni P., Shirihai O., Meluh P.B., Pandolfi P.P., Zon L.I. SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell. 10:2002;843-855.
3. Bhaskar V., Smith M., Courey A.J. Conjugation of Smt3 to dorsal may potentiate the Drosophila immune response. Mol. Cell. Biol. 22:2002;492-504.
4. Billon N., Carlisi D., Datto M.B., van Grunsven L.A., Watt A., Wang X.F., Rudkin B.B. Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene. 18:1999;2872-2882.
5. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188:2001;143-160.
6. Borden K.L. Pondering the promyelocytic leukemia protein (PML) puzzle. possible functions for PML nuclear bodies Mol. Cell. Biol. 22:2002;5259-5269.
7. Bouwman P., Gollner H., Elsasser H.P., Eckhoff G., Karis A., Grosveld F., Philipsen S., Suske G. Transcription factor Sp3 is essential for post-natal survival and late tooth development. EMBO J. 19:2000;655-661.
8. Braun H., Koop R., Ertmer A., Nacht S., Suske G. Transcription factor Sp3 is regulated by acetylation. Nucleic Acids Res. 29:2001;4994-5000.
9. De Luca P., Majello B., Lania L. Sp3 represses transcription when tethered to promoter DNA or targeted to promoter proximal RNA. J. Biol. Chem. 271:1996;8533-8536.
10. Dennig J., Beato M., Suske G. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. EMBO J. 15:1996;5659-5667.
11. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell. 2:1998;233-239.
12. Everett R.D., Lomonte P., Sternsdorf T., van Driel R., Orr A. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112:1999;4581-4588.
13. Gill G., Pascal E., Tseng Z.H., Tjian R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc. Natl. Acad. Sci. USA. 91:1994;192-196.
14. Gollner H., Dani C., Phillips B., Philipsen S., Suske G. Impaired ossification in mice lacking the transcription factor Sp3. Mech. Dev. 106:2001;77-83.
15. Gong L., Millas S., Maul G.G., Yeh E.T. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275:2000;3355-3359.
16. Goodson M.L., Hong Y., Rogers R., Matunis M.J., Park-Sarge O.K., Sarge K.D. Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J. Biol. Chem. 276:2001;18513-18518.
17. Gostissa M., Hengstermann A., Fogal V., Sandy P., Schwarz S.E., Scheffner M., Del Sal G. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18:1999;6462-6471.
18. Hagen G., Muller S., Beato M., Suske G. Cloning by recognition site screening of two novel GT box binding proteins. a family of Sp1 related genes Nucleic Acids Res. 20:1992;5519-5525.
19. Hagen G., Muller S., Beato M., Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13:1994;3843-3851.
20. Hahn S.L., Wasylyk B., Criqui-Filipe P., Criqui P. Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzyme. Oncogene. 15:1997;1489-1495.
21. Hang J., Dasso M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J. Biol. Chem. 277:2002;19961-19966.
22. Haviv I., Vaizel D., Shaul Y. The X protein of hepatitis B virus coactivates potent activation domains. Mol. Cell. Biol. 15:1995;1079-1085.
23. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature. 419:2002;135-141.
24. Hong Y., Rogers R., Matunis M.J., Mayhew C.N., Goodson M., Park-Sarge O.K., Sarge K.D. Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J. Biol. Chem. 276:2001;40263-40267.
25. Iniguez-Lluhi J.A., Pearce D. A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol. Cell. Biol. 20:2000;6040-6050.
26. Kennett S.B., Udvadia A.J., Horowitz J.M. Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25:1997;3110-3117.
27. Kingsley C., Winoto A. Cloning of GT box-binding proteins. a novel Sp1 multigene family regulating T-cell receptor gene expression Mol. Cell. Biol. 12:1992;4251-4261.
28. Kumar A.P., Butler A.P. Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1. Nucleic Acids Res. 25:1997;2012-2019.
29. LaMorte V.J., Dyck J.A., Ochs R.L., Evans R.M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA. 95:1998;4991-4996.
30. Liang Y., Robinson D.F., Dennig J., Suske G., Fahl W.E. Transcriptional regulation of the SIS/PDGF-B gene in human osteosarcoma cells by the Sp family of transcription factors. J. Biol. Chem. 271:1996;11792-11797.
31. Mahajan R., Delphin C., Guan T., Gerace L., Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 88:1997;97-107.
32. Majello B., De Luca P., Hagen G., Suske G., Lania L. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:1994;4914-4921.
33. Majello B., De Luca P., Suske G., Lania L. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins. Oncogene. 10:1995;1841-1848.
34. Majello B., De Luca P., Lania L. Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J. Biol. Chem. 272:1997;4021-4026.
35. Matunis M.J., Coutavas E., Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135:1996;1457-1470.
36. Matunis M.J., Wu J., Blobel G. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol. 140:1998;499-509.
37. Melchior F. SUMO-nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16:2000;591-626.
38. Muller S., Matunis M.J., Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:1998;61-70.
39. Muller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275:2000;13321-13329.
40. Muller S., Hoege C., Pyrowolakis G., Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2:2001;202-210.
41. Nishida T., Tanaka H., Yasuda H. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 267:2000;6423-6427.
42. Noti J.D. Sp3 mediates transcriptional activation of the leukocyte integrin genes CD11C and CD11B and cooperates with c-Jun to activate CD11C. J. Biol. Chem. 272:1997;24038-24045.
43. Philipsen S., Suske G. A tale of three fingers. the family of mammalian Sp/XKLF transcription factors Nucleic Acids Res. 27:1999;2991-3000.
44. Pichler A., Gast A., Seeler J.S., Dejean A., Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 108:2002;109-120.
45. Poukka H., Aarnisalo P., Karvonen U., Palvimo J.J., Janne O.A. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J. Biol. Chem. 274:1999;19441-19446.
46. Poukka H., Karvonen U., Janne O.A., Palvimo J.J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA. 97:2000;14145-14150.
47. Rodriguez M.S., Desterro J.M., Lain S., Midgley C.A., Lane D.P., Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:1999;6455-6461.
48. Rodriguez M.S., Dargemont C., Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:2001;12654-12659.
49. Ross S., Tienhaara A., Lee M.S., Tsai L.H., Gill G. GC box-binding transcription factors control the neuronal specific transcription of the cyclin-dependent kinase 5 regulator p35. J. Biol. Chem. 277:2002;4455-4464.
50. Rudnicki M.A., McBurney M.W. Cell culture methods and induction of differentiation of embryonal carcinoma cell lines. Robertson E. Teratocarcinoma and Embryonic Stem Cells. A Pratical Approach. 1987;IRL Press, Oxford/Washington, DC. 19-50.pp.
51. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:2001;3088-3103.
52. Sadowski I., Ma J., Triezenberg S., Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature. 335:1988;563-564.
53. Salghetti S.E., Caudy A.A., Chenoweth J.G., Tansey W.P. Regulation of transcriptional activation domain function by ubiquitin. Science. 293:2001;1651-1653.
54. Seeler J.S., Marchio A., Losson R., Desterro J.M., Hay R.T., Chambon P., Dejean A. Common properties of nuclear body protein SP100 and TIF1α chromatin factor. role of SUMO modification Mol. Cell. Biol. 21:2001;3314-3324.
55. Sjottem E., Anderssen S., Johansen T. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3′ to the TATA box. J. Virol. 70:1996;188-198.
56. Suske G. The Sp-family of transcription factors. Gene. 238:1999;291-300.
57. Suzuki T., Ichiyama A., Saitoh H., Kawakami T., Omata M., Chung C.H., Kimura M., Shimbara N., Tanaka K. A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain. J. Biol. Chem. 274:1999;31131-31134.
58. Udvadia A.J., Templeton D.J., Horowitz J.M. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members. superactivation by Rb requires amino acids necessary for growth suppression Proc. Natl. Acad. Sci. USA. 92:1995;3953-3957.
59. Zhong S., Muller S., Ronchetti S., Freemont P.S., Dejean A., Pandolfi P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood. 95:2000;2748-2752. a.
60. Zhong S., Salomoni P., Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2:2000;E85-E90. b.